🇺🇸 Antithyroid Drug in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 12

Most-reported reactions

1. Alopecia — 2 reports (16.67%)
2. Inappropriate Schedule Of Drug Administration — 2 reports (16.67%)
3. Abdominal Abscess — 1 report (8.33%)
4. Abnormal Loss Of Weight — 1 report (8.33%)
5. Amenorrhoea — 1 report (8.33%)
6. Application Site Pruritus — 1 report (8.33%)
7. Arthropathy — 1 report (8.33%)
8. Body Height Decreased — 1 report (8.33%)
9. Cerebrovascular Disorder — 1 report (8.33%)
10. Contraindicated Drug Administered — 1 report (8.33%)

Source database →

Frequently asked questions

Is Antithyroid Drug approved in United States?

Antithyroid Drug does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Antithyroid Drug in United States?

Seoul St. Mary's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.